Loading...
NPI 1942532189 · Phoenix, AZ · Public Health or Welfare Agency
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
The Arizona Partnership For Immunization is a public health or welfare agency provider located in Phoenix, Arizona. This profile covers 16 Medicare and 105 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | The Arizona Partnership For Immunization |
| Address | 3838 N Central Ave Ste 1650 |
| City | Phoenix |
| State | AZ |
| ZIP | 85012 |
| Taxonomy | Public Health or Welfare Agency |
| NPI Enumerated | February 12, 2010 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $12.1M |
| Medicare | $162.9K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
16 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 460 | $140 | $65.2K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 650 | $40 | $26.2K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 190 | $130 | $24.1K |
| 0134A | N/A | 260 | $40 | $10.4K |
| G0008 | Administration of influenza virus vaccine | 330 | $30 | $9.9K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 30 | $270 | $6.7K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 80 | $70 | $5.5K |
| 0124A | N/A | 130 | $40 | $5.2K |
| 90688 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It uses split virus technology and is given as a 0.5 mL dose. | 150 | $20 | $2.9K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 30 | $70 | $2.3K |
Showing 1–10 of 16
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
16 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 91320 | 92 | 410 | 60 | $130 | $15.7K |
| 91322 | 13 | 520 | 70 | $140 | $15K |
| 90677 | 471 | 1,070 | 20 | $280 | $8.3K |
| 90694 | 471 | 690 | 50 | $70 | $7.9K |
| 90480 | 10 | 770 | 100 | $30 | $4.9K |
| 90662 | 409 | 1,550 | 40 | $70 | $4.8K |
| G0008 | 117 | 2,140 | 40 | $30 | $2.6K |
| 91304 | 3 | 10 | 20 | $130 | $2.5K |
| 90732 | 73 | 80 | 20 | $130 | $2.5K |
| 0134A | 4 | 270 | 30 | $40 | $2K |
Showing 1–10 of 16
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
105 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 90460 | In this procedure, the provider administers a single live attenuated vaccine through a parenteral, oral, intranasal, intramuscular, or intravenous to a patient up to 18 years of age. | 104,580 | $50 | $4.7M |
| 90739 | This code represents an adult–dosage vaccine product administered intramuscularly to protect against the liver disease hepatitis B. The product has a synthetic DNA called CpG added to improve the… | 7,350 | $140 | $999.2K |
| 90716 | The provider administers a live vaccine subcutaneously to protect against varicella infection. | 17,840 | $50 | $963.6K |
| 90651 | This code represents a nonavalent human papillomavirus (HPV) vaccine product administered into the muscle to protect against HPV infection. The vaccine protects against nine HPV types (6, 11, 16, 18,… | 29,540 | $20 | $708.9K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 29,750 | $20 | $684.1K |
| 90707 | This code represents an MMR vaccine product administered beneath the skin to protect against measles, mumps, and rubella (German measles). | 14,460 | $40 | $607.5K |
| 90632 | This code represents a vaccine product administered into a muscle to protect against hepatitis A, a liver infection. This code is specific to an adult dosage. | 12,110 | $40 | $496.6K |
| 90472 | This code represents each injection of a vaccine after the first; list this code in addition to the code for the first injection. | 11,450 | $30 | $320.5K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 2,680 | $110 | $281.7K |
| 90715 | The provider uses this combination vaccine as a booster to help protect patients who are 7 years old or older from lockjaw, diphtheria, and whooping cough. | 36,080 | $10 | $252.6K |
Showing 1–10 of 105
How this provider's Medicaid billing volume and revenue compare to other Arizona providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arizona median
105 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 75 | 100 | 1,040 | $20 | $327.4K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 75 | 100 | 1,120 | $10 | $311.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,945 | 2,780 | 600 | $50 | $267K |
| 90460 | In this procedure, the provider administers a single live attenuated vaccine through a parenteral, oral, intranasal, intramuscular, or intravenous to a patient up to 18 years of age. | 2 | 420 | 600 | $30 | $177K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 634 | 1,030 | 130 | $70 | $134.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 954 | 1,160 | 150 | $90 | $96.5K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 532 | 850 | 230 | $40 | $72.5K |
| 90739 | This code represents an adult–dosage vaccine product administered intramuscularly to protect against the liver disease hepatitis B. The product has a synthetic DNA called CpG added to improve the… | 1 | 20 | 20 | $120 | $59.5K |
| 90461 | In this procedure, the provider administers an additional live attenuated vaccine either via a parenteral, oral, intranasal, intramuscular, or intravenous to a patient up to 18 years of age after the… | 88 | 150 | 320 | $20 | $40.6K |
| 90632 | This code represents a vaccine product administered into a muscle to protect against hepatitis A, a liver infection. This code is specific to an adult dosage. | 1 | 10 | 40 | $40 | $39.1K |
Showing 1–10 of 105
Other providers in the same ZIP code as The Arizona Partnership For Immunization, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.